452 related articles for article (PubMed ID: 29095917)
1. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.
Parsons BN; Ijaz UZ; D'Amore R; Burkitt MD; Eccles R; Lenzi L; Duckworth CA; Moore AR; Tiszlavicz L; Varro A; Hall N; Pritchard DM
PLoS Pathog; 2017 Nov; 13(11):e1006653. PubMed ID: 29095917
[TBL] [Abstract][Full Text] [Related]
2. Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.
Paroni Sterbini F; Palladini A; Masucci L; Cannistraci CV; Pastorino R; Ianiro G; Bugli F; Martini C; Ricciardi W; Gasbarrini A; Sanguinetti M; Cammarota G; Posteraro B
Appl Environ Microbiol; 2016 Nov; 82(22):6633-6644. PubMed ID: 27590821
[TBL] [Abstract][Full Text] [Related]
3. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
4. Infection of
Iino C; Shimoyama T; Chinda D; Arai T; Chiba D; Nakaji S; Fukuda S
Front Immunol; 2018; 9():712. PubMed ID: 29681906
[TBL] [Abstract][Full Text] [Related]
5. Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication.
Müller H; Rappel S; Wündisch T; Bayerdörffer E; Stolte M
Digestion; 2001; 64(1):30-9. PubMed ID: 11549834
[TBL] [Abstract][Full Text] [Related]
6. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection.
Veijola LI; Oksanen AM; Sipponen PI; Rautelin HI
World J Gastroenterol; 2010 Jan; 16(1):83-8. PubMed ID: 20039453
[TBL] [Abstract][Full Text] [Related]
7. Atrophic corpus gastritis and Helicobacter pylori infection in primary biliary cirrhosis.
Dohmen K; Shigematsu H; Miyamoto Y; Yamasaki F; Irie K; Ishibashi H
Dig Dis Sci; 2002 Jan; 47(1):162-9. PubMed ID: 11837719
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.
Park CH; Lee AR; Lee YR; Eun CS; Lee SK; Han DS
Helicobacter; 2019 Feb; 24(1):e12547. PubMed ID: 30440093
[TBL] [Abstract][Full Text] [Related]
9. Treatment of
Lahner E; Carabotti M; Annibale B
World J Gastroenterol; 2018 Jun; 24(22):2373-2380. PubMed ID: 29904244
[No Abstract] [Full Text] [Related]
10. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
[TBL] [Abstract][Full Text] [Related]
11. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: evaluation in a country of high prevalence of atrophic gastritis.
Ito M; Haruma K; Kaya S; Kamada T; Kim S; Sasaki A; Sumii M; Tanaka S; Yoshihara M; Chayama K
Scand J Gastroenterol; 2002 Mar; 37(3):287-93. PubMed ID: 11916190
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and helicobacter pylori-associated pathogenesis.
Hagiwara T; Mukaisho K; Nakayama T; Hattori T; Sugihara H
Asian Pac J Cancer Prev; 2015; 16(4):1315-9. PubMed ID: 25743791
[TBL] [Abstract][Full Text] [Related]
13. Chronic Atrophic Gastritis: A Review.
Li Y; Xia R; Zhang B; Li C
J Environ Pathol Toxicol Oncol; 2018; 37(3):241-259. PubMed ID: 30317974
[TBL] [Abstract][Full Text] [Related]
14. Remodeling of the gastric environment in
Shuman JHB; Lin AS; Westland MD; Bryant KN; Piazuelo MB; Reyzer ML; Judd AM; McDonald WH; McClain MS; Schey KL; Algood HMS; Cover TL
mSystems; 2024 Jan; 9(1):e0109823. PubMed ID: 38059647
[No Abstract] [Full Text] [Related]
15. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.
Kim N
J Gastroenterol Hepatol; 2019 Aug; 34(8):1287-1295. PubMed ID: 30828872
[TBL] [Abstract][Full Text] [Related]
16. Role of Helicobacter pylori serology in atrophic body gastritis after eradication treatment.
Lahner E; Bordi C; Di Giulio E; Caruana P; D'Ambra G; Milione M; Grossi C; Delle Fave G; Annibale B
Aliment Pharmacol Ther; 2002 Mar; 16(3):507-14. PubMed ID: 11876704
[TBL] [Abstract][Full Text] [Related]
17. Low co-existence rates of Lactobacillus spp. and Helicobacter pylori detected in gastric biopsies from patients with gastrointestinal symptoms.
García A; Sáez K; Delgado C; González CL
Rev Esp Enferm Dig; 2012 Sep; 104(9):473-8. PubMed ID: 23130855
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection and gastric autoimmune diseases: is there a link?
Presotto F; Sabini B; Cecchetto A; Plebani M; De Lazzari F; Pedini B; Betterle C
Helicobacter; 2003 Dec; 8(6):578-84. PubMed ID: 14632671
[TBL] [Abstract][Full Text] [Related]
19. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
[TBL] [Abstract][Full Text] [Related]
20. Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD.
Mukaisho K; Hagiwara T; Nakayama T; Hattori T; Sugihara H
World J Gastroenterol; 2014 Sep; 20(34):11962-5. PubMed ID: 25232231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
